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Pharmaceutical Chemistry
is in a pandemic state hence currently a great international 
concern.[1] Many potential drug molecules have been 
discovered to inhibit a specific part of the viral lifecycle 
as a current approach to control the disease.[2] An area 
of much recent progress has been that of HIV integrase 
inhibitor design. Integrase is an essential enzyme for viral 
replication, and it has no human homolog.[3] Integrase 
catalyzes the insertion of reverse-transcribed viral cDNA 
into the host cell genome via a multi-step process. The 
first step in integration occurs in the host cell cytosol 
and is referred to as 3’ end processing. During this step, 
integrase cleaves a dinucleotide from each viral DNA 
terminus at a conserved sequence, yielding two reactive 3’ 
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ABSTRACT
Elvitegravir is a new-generation drug which acts as an integrase inhibitor of the HIV virus. The potential inhibition 
has been tested from the clinical trial data. Here the work basically deals with the quantitative structure-activity 
relationship (QSAR) analysis by considering some of the physiochemical descriptors like molecular weight, logP, 
molar volume, and structural descriptors like Winers index, and molecular topological index of the drug analogs. 
The descriptors were calculated from the E-Dragon server and the multiple linear regression equation models 
were built by using Minitab tools. The different combinations of structural and physiochemical descriptors were 
considered for model derivation. The best three models were chosen by observing high R-Sq value, high F-value 
and low residual errors. The P values (regression) for the three models indicates the significance of the consi
dered descriptors.The overall results obtained with these model suggest that for this perticular drug the activity 
is dependent on physiochemical descriptors. 
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hydroxyl groups. After this processing step a number of 
viral and cellular proteins form a complex which is known 
as pre-integration complex (PIC), and then migrates to the 
nucleus. Within the nucleus the reactive hydroxyl groups are 
utilized in nucleophilic attack upon the host cell genome, 
a process known as strand transfer.[4] Elvitegravir is a 
potential drug for HIV integrase enzyme inhibitor which 
is in its Phase III clinical trials.[5,6]
To analyze different potential drug molecules the 
quantitative structure-activity relationship (QSAR) method 
is a useful approach. QSAR is basically used to study the 
biological activities with various properties associated with 
the structures, which is helpful to explain how structural 
features in a drug molecule influence the biological 
activities. Also a successful in silico-based QSAR analysis 
provides the advantages of higher speed and lower costs 
for bioactivity evaluation as compared to experimental 
testing.[7] Therefore, correlating the physiochemical 
properties or structural features of the integrase inhibitor 
compounds with their biological activity will surely provide 
useful information for the design of new HIV drugs. To 
address this issue, an in silico approach has been adopted 
to calculate some selected physiochemical and structural 
descriptors of Elvitegravir analogs. Quantitative structural 
activity relationship study has been done by taking 
combinations of different physiological and structural 
descriptors by multiple linear regressions analysis to figure 
out the major molecular factor as associated with the 
activity of the drug molecule.
MATERIALS AND METHODS
All 26 analogs of the drug molecule Elvitegravir along 
with the IC50 value were obtained from the literature[8] 
and corresponding log IC50 values were calculated. The 
derivatives of the Elvitegravir molecules were drawn 
in Marvin sketch 5.0 tools.[9] Then the molecules were 
subjected to energy minimization by Prodrg server.[10] 
Prodrg is an online server where the energy minimization 
of the molecule was performed by using Gromos 96 
force field. The various descriptors considered for the 
present work were molecular weight (MW), molar volume 
(MV), LogP (Octanol/Water partition co efficient) as 
physiochemical descriptors, and molecular topological 
index (MTI), Wiener index (WI), and total E-state 
topological parameter (TIE) as structural descriptors for 
the molecules. All these descriptors were calculated by the 
E-Dragon server.[11] The different combinations of the 
above two types of descriptors were subjected to multiple 
regression analysis by MINITAB 14 software.[12] For the 
best model selection various parameters like high F value, 
R-Sq and P value were chosen from regression analysis and 
equations were derived. From the equations the predicted 
and experimental log IC50 values were compared.
RESULTS
In the present study an attempt has been made to develop 
the best QSAR model to explain the correlation between 
the combined effect of physiochemical and structural 
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descriptors for the 26 Elvitegravir drug analogs [Table 1]. 
After calculation of the descriptors for all molecules and 
multiple linear regression analysis by the MINITAB 14 
tool the following best three mathematical equations were 
derived.
Log IC 50 = 4.71 + 0.0116 MW – 0.0514 MV – 0.0911 
LogP – 0.0741 WI – 9.67 SMTI (Eq.1)
Log IC 50 = 1.47 + 0.0130 MW – 0.0481 MV – 0.101 
LogP – 0.0701 WI + 0.106 TIE (Eq.2)
Log IC 50 = 5.18 + 0.0108 MW – 0.0564 MV – 0.0660 
WI – 11.4 SMTI + 0.022 TIE (Eq.3)
The statistics from all three models exhibit the dependency to 
both structural and physiochemical descriptors are presented 
in the above equations. Inorder to confirm our results Log 
IC50 values were predicted from the above equations and 
results were compared to previously calculated ones. Such 
correlations for the above three equations have been given 
in Figures 1-3 respectively.
DISCUSSION
In general the topological and structural descriptors are very 
important types of molecular descriptors for bioactivity 
prediction.[13] However, in our multiple linear regression 
analysis it was observed that among the above descriptors 
the structural descriptors are less important for anti-HIV 
activities. All the statistics of the equations have been 
considered to exhibit the structural and physiological 
parameters to model the Log IC50 value of the drug 
analogs. Comparing the variance value (R-Sq) among the 
equations [Table 2], the variances decrease when more 
independent variables (descriptors) for the structural type 
were considered. For the same set of descriptors (Eq.1 
and Eq.2) only two combinations of structural descriptors 
showed less change in variance value (R-Sq), however, when 
three structural descriptors (Eq.3) were considered, the 
variance value were observed as it decreases significantly. 
Also, P value for regression was observed to be 0.000 in all 
the selected models in Minitab calculations. Since the value 
is less than the level of signicance (0.005) so it indicates 
the validity of the considered descriptors. Further, 3D 
descriptor calculation and QSAR model building would 
provide the features that significantly contribute to the 
physiochemical property which is related to the activity of 
the drug. Our results show that the anti-HIV activity of the 
Elvitegravir derivatives can be successfully modeled with 
some selected physiochemical and structural descriptors. 
In this method, the reliable prediction obtained can be 
successfully used for determining the anti-HIV activity 
of drugs.
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Table 2: Calculation of statistical parameters for the 
best model consideration
Model number R-Sq value (%) F value P value
1 76.7 13.86 0.000
2 73.1 11.40 0.000
3 69.7 9.66 0.000
Figure 1: Plot between calculated and predicted value for Log IC50 
(Model 1)
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Figure 3: Plot between calculated and predicted value for Log IC50 
(Model 3)
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Figure 2: Plot between calculated and predicted value for Log IC50 
(Model 2)
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